Therapeutic Drug Monitoring of Beta-lactams and Renal Hyperclearance in Patients Admitted to Intensive Care for Acute Brain Injury

Abroad (travel likely)Recruiting

Conditions

Critical Illness · Brain Injuries

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations
  • CHU de Nîmes - Hôpital Universitaire Carémeau, Nîmes, France

    Contact: Study coordinator (Claire ROGER, MD, PhD)
    Contact: Principal Investigator (Claire ROGER, MD, PhD)